Jun Hyuk Lee

Jun Hyuk Lee

Auto-generated profile, based on publicly available information

Jun Hyuk Lee

Health and Human Science, University of Southern California, Los Angeles, CA, United States

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SHSeung Ha Hwang
Seung Ha Hwang
HLHayeon Lee
Hayeon Lee
JLJun Hyuk Lee
Jun Hyuk Lee
MLMyeongcheol Lee
Myeongcheol Lee
AKAi Koyanagi
Ai Koyanagi
Jinseok LeeJinseok Lee
Jinseok Lee
Background: Worldwide, cardiovascular diseases are the primary cause of death, with hypertension as a key contributor. In 2019, cardiovascular diseases led to 17.9 million deaths, predicted to reach 23 million by 2030. Objective: This study presents a new method to predict hypertension using demographic data, using 6 machine learning models for enhanced reliability and applicability. The goal is to harness artificial intelligence for early and accurate hypertension diagnosis across diverse populations. Methods: Data from 2 national cohort studies, National Health Insurance Service-National Sample Cohort (South Korea, n=244,814), conducted between 2002 and 2013 were used to train and test machine learning models designed to anticipate incident hypertension within 5 years of a health checkup involving those aged ≥20 years, and Japanese Medical Data Center cohort (Japan, n=1,296,649) were used for extra validation. An ensemble from 6 diverse machine learning models was used to identify the 5 most salient features contributing to hypertension by presenting a feature importance analysis to confirm the contribution of each future. Results: The Adaptive Boosting and logistic regression ensemble showed superior balanced accuracy (0.812, sensitivity 0.806, specificity 0.818, and area under the receiver operating characteristic curve 0.901). The 5 key hypertension indicators were age, diastolic blood pressure, BMI, systolic blood pressure, and fasting blood glucose. The Japanese Medical Data Center cohort dataset (extra validation set) corroborated these findings (balanced accuracy 0.741 and area under the receiver operating characteristic curve 0.824). The ensemble model was integrated into a public web portal for predicting hypertension onset based on health checkup data. Conclusions: Comparative evaluation of our machine learning models against classical statistical models across 2 distinct studies emphasized the former’s enhanced stability, generalizability, and reproducibility in predicting hypertension onset.

1 November 2024 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
SHSeohyun Hong
Seohyun Hong
YSYejun Son
Yejun Son
MLMyeongcheol Lee
Myeongcheol Lee
JLJun Hyuk Lee
Jun Hyuk Lee
JPJaeyu Park
Jaeyu Park
DYDong Keon Yon
Dong Keon Yon
Background: The imperative arises to study the impact of socioeconomic factors on the acceptance of SARS-CoV-2 and influenza vaccines amid changes in immunization policies during the COVID-19 pandemic. Objective: To enhance targeted public health strategies and improve age-specific policies based on identified risk factors, this study investigated the associations between sociodemographic factors and vaccination behaviors during the COVID-19 pandemic, with emphasis on age-specific vaccine cost policies. Methods: This study analyzed data from the Korean Community Health Survey 2019‐2022 with 507,964 participants to investigate the impact of age-specific policies on vaccination behaviors during the pandemic period. Cohorts aged 19‐64 years and 65 years or older were stratified based on age (years), sociodemographic factors, and health indicators. The cohorts were investigated to assess the influence of relevant risk factors on vaccine acceptance under the pandemic by using weighted odds ratio and ratio of odds ratio (ROR). Results: Among 507,964 participants, the acceptance of the SARS-CoV-2 vaccine (COVID-19 vaccine) was higher among individuals with factors possibly indicating higher socioeconomic status, such as higher education level (age 19‐64 years: ROR 1.34; 95% CI 1.27‐1.40 and age ≥65 years: ROR 1.19; 95% CI 1.01‐1.41) and higher income (age 19‐64 years: ROR 1.67; 95% CI 1.58‐1.76 and age ≥65 years: ROR 1.21; 95% CI 1.06‐1.38) for both age cohorts compared to influenza vaccine acceptance before the pandemic. In the context of influenza vaccination during the pandemic, the older cohort exhibited vaccine hesitancy associated with health care mobility factors such as lower general health status (ROR 0.89; 95% CI 0.81‐0.97). Conclusions: SARS-CoV-2 vaccination strategies should focus on reducing hesitancy among individuals with lower social participation. To improve influenza vaccine acceptance during the pandemic, strategies for the younger cohort should focus on individuals with lower social participation, while efforts for the older cohort should prioritize individuals with limited access to health care services.

1 January 2024 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
JKJeewoo Kang
Jeewoo Kang
JPJaeyu Park
Jaeyu Park
HJHyesu Jo
Hyesu Jo
HLHyeri Lee
Hyeri Lee
KLKyeongmin Lee
Kyeongmin Lee
DYDong Keon Yon
Dong Keon Yon
Kang J, et al. Allergy Asthma Immunol Res. 2024 Nov;16(6):613-625. https://doi.org/10.4168/aair.2024.16.6.613

1 November 2024 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
SPSeoyoung Park
Seoyoung Park
YSYejun Son
Yejun Son
HLHyeri Lee
Hyeri Lee
HLHayeon Lee
Hayeon Lee
Jinseok LeeJinseok Lee
Jinseok Lee
DYDong Keon Yon
Dong Keon Yon
Background: Osteoarthritis and rheumatoid arthritis (RA) are prevalent chronic joint disorders, with prevalence rates varying by sex. However, few studies have comprehensively documented the factors contributing to the sex-specific prevalence of osteoarthritis and RA, including sociological factors and the impact of the COVID-19 pandemic. Objective: This study aims to identify long-term trends in the sex-specific prevalence of osteoarthritis and RA from 2005 to 2021 while examining the factors that serve as vulnerabilities specific to each sex within the context of the COVID-19 pandemic. Methods: Data were collected from a nationally representative sample of 110,225 individuals through the Korea National Health and Nutrition Examination Survey from 2005 to 2021. The study included patients aged 19 years and older diagnosed with osteoarthritis or RA in South Korea. Data were analyzed using weighted trends to accurately represent the sample population, with a 95% CI. Weighted logistic and regression models were used to identify vulnerable groups at risk of osteoarthritis or RA during the pandemic to assess sex-specific trends. Results: In total, 110,225 individuals (n=48,410, 43.92% male participants) were analyzed from 2005 to 2021, with prevalence rates remaining stable over time and higher in female than in male participants. Notably, during the pandemic, female participants aged 60 years and older exhibited a prevalence of osteoarthritis that was 4.92 times greater than male participants and a prevalence of RA that was 6.44 times greater (osteoarthritis: prevalence ratio [PR] 69.78, 95% CI 41.66-116.88; RA: PR 17.27, 95% CI 8.75-34.07). In terms of osteoarthritis, male participants did not show a significant association with BMI (PR 1.40, 95% CI 1.21-1.61; P=.47), whereas female participants exhibited a significantly higher vulnerability within the obese group (PR 1.68, 95% CI 1.55-1.83; P<.001). Regarding RA, lower education levels were associated with increased vulnerability, with male participants showing a greater risk than female participants (male participants: PR 2.29, 95% CI 1.61-3.27 and female participants: PR 1.50, 95% CI 1.23-1.84). Conclusions: This study reveals that women in South Korea have a higher prevalence of osteoarthritis and RA than men. Understanding these sex-specific trends and identifying vulnerability factors can enhance preventive efforts and patient care.

30 July 2024 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
HLHyeri Lee
Hyeri Lee
MKMinji Kim
Minji Kim
SWSelin Woo
Selin Woo
JPJaeyu Park
Jaeyu Park
HKHyeon Jin Kim
Hyeon Jin Kim
DYDong Keon Yon
Dong Keon Yon
Background: Understanding the association between hypertension prevalence and socioeconomic and behavioral variables during a pandemic is essential, and this analysis should extend beyond short-term trends. Objective: This study aims to examine long-term trends in the prevalence of participants diagnosed with and receiving treatment for hypertension, using data collected by a nationally representative survey from 2009 to 2022, which includes the COVID-19 pandemic era. Methods: A nationwide, population-based, cross-sectional study used data collected from the South Korea Community Health Survey between 2009 and 2022. The study sample comprised 3,208,710 Korean adults over a period of 14 years. We aimed to assess trends in the prevalence of participants diagnosed with and receiving treatment for hypertension in the national population from 2009 to 2022, with a specific focus on the COVID-19 pandemic, using weighted linear regression models. Results: Among the included 3,072,546 Korean adults, 794,239 (25.85%) were aged 19-39 years, 1,179,388 (38.38%) were aged 40-59 years; 948,097 (30.86%) were aged 60-79 years, and 150,822 (4.91%) were aged 80 years or older. A total of 1,426,379 (46.42%) were men; 761,896 (24.80%) and 712,264 (23.18%) were diagnosed with and received treatment for hypertension, respectively. Although the overall prevalence over the 14-year period increased, the upward trends of patients diagnosed with and receiving treatment for hypertension decreased during the COVID-19 pandemic era compared with the prepandemic era (β difference for trend during vs before the pandemic –.101, 95% CI –0.107 to –0.094 vs –.133, 95% CI –0.140 to –0.127). Notably, the trends in prevalence during the pandemic were less pronounced in subgroups of older adults (≥60 years old) and individuals with higher alcohol consumption (≥5 days/month). Conclusions: This nationwide representative study found that the national prevalence of participants diagnosed with and receiving treatment for hypertension increased during the prepandemic era. However, there was a marked decrease in these trends during the prepandemic era, compared with the pandemic era, particularly among specific subgroups at increased risk of negative outcomes. Future studies are needed to evaluate the factors associated with changes in the prevalence of hypertension during the COVID-19 pandemic.

18 June 2026 in Neuropsychology Review
Verified
Journal Article
Open access
PDF file
JTJason M. Toliao
Jason M. Toliao
JLJunhyuk Lee
Junhyuk Lee
HOHans Oh
Hans Oh
SLSan LEE
San LEE
LCLucas Conner
Lucas Conner
PCPradip P. Chaudhari
Pradip P. Chaudhari
An increasing number of systematic reviews and meta-analyses examine health outcomes from traumatic brain injury (TBI). This umbrella review examines the association of TBI with comorbid health outcomes and evaluates the methodological rigor of existing literature. This protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO; Registration No. CRD42024581341). EMBASE, PubMed, MEDLINE, and the Cochrane Library were searched from database inception to November 26, 2025. Two reviewers screened abstracts and full texts using predefined criteria. Meta-analyses of observational studies were included if they assessed health outcomes following TBI and reported effect sizes were convertible to pooled equivalent odds ratios (eOR). PRISMA (Preferred Reporting Items of Systematic Reviews and Meta-Analyses) guidelines were utilized for study formatting. We applied AMSTAR2 (A Measurement Tool to Assess Systematic Reviews 2) criteria to assess the quality of included studies. Health outcomes described in each meta-analysis were reanalyzed and presented through eOR using a random-effects model. 41 meta-analyses were included, covering 671 original studies and 53 comorbid health outcomes, in a cohort comprising 83 million participants across 40 countries. Our findings suggest that traumatic brain injury, acquired at any age, may be associated with impairments across neurological, somnological, cognitive, mental health, and behavioral domains. Despite these associations, 78% of the included studies were themselves classified as having “critically low” methodological quality by AMSTAR2 criteria, which limited the ability to provide causal conclusions. These findings may help inform care guidelines following TBI. Improved research frameworks are important to better understand the lasting effects of TBI.